MECHANISMS OF RADIATION-INDUCED KIDNEY INJURY
辐射肾损伤的机制
基本信息
- 批准号:2017346
- 负责人:
- 金额:$ 19.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-06-10 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:X ray angiotensin II animal genetic material tag blood vessel disorder enzyme activity enzyme induction /repression extracellular matrix proteins immunocytochemistry injury kidney disorder laboratory rat nitric oxide nitric oxide synthase northern blottings polymerase chain reaction radiation genetics radiobiology renal glomerulus tissue /cell culture transforming growth factors vascular endothelium
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract): Radiation-induced
renal injury is a major complication of radiotherapy, particularly in
patients subjected to total body irradiation for bone marrow
transplantation. The nephropathy may progress to end stage renal disease.
Because of the growing number of bone marrow transplants performed,
characterization and prevention of progression of radiation nephropathy is
of major concern. There is a big gap in our understanding of the injury and
causing its progression to irreversible stages. Extracellular matrix
synthesis (scarring) in renal glomerular capillary and endothelial injury
are key characteristics. Glomerular scarring is indicative of enhanced
expression and synthesis of factors that promote fibrogenesis. On the other
hand, injury of the glomerular capillary endothelium may indicate that the
synthesis of endothelium-derived factors may become perturbed thereby
causing renal hemodynamic impairment. We have shown that angiotensin II
(AII) synthesis inhibition preserves renal function and structure in a rat
model of radiation nephropathy. This implicates biologic events triggered
by AII as potential mechanisms underlying the pathogenesis of radiation
nephropathy. Two likely events are, synthesis of the ECM promoting factor
Transformng Growth Factor (TGF)-b1 and generation of the endothelium-derived
vasodilator, nitric oxide. The proposed studies will use a rat model of
radiation nephropathy to test the following hypotheses:
1) In radiation-induced nephropathy there is enhanced synthesis of specific
extracellular matrix (ECM) proteins and enhanced expression of TGF-b1 which
promotes synthesis of these ECM proteins. AII inhibition attenuates TGF-b1
expression and synthesis of ECM proteins. 2) In radiation-induced
nephropathy there is injury of the glomerular capillary endothelium. This
results in impaired production of the endothelium-derived vasodilator,
nitric oxide (NO), thereby changing pressures and flows in the glomerular
microvasculature. AII synthesis inhibition restores or promotes NO
generation thereby ameliorating renal ischemia. It is anticipated that the
observations will enhance our understanding of the pathobiology of
radiation-induced injury and provide means to avert its progression to
irreversible stages.
描述:(改编自申请人摘要):辐射诱导
肾损伤是放射治疗的主要并发症,特别是在
接受骨髓全身照射的患者
移植 肾病可能进展为终末期肾病。
由于越来越多的骨髓移植手术,
放射性肾病的特征和预防进展是
主要关注点。 我们对伤病的理解有很大的差距,
导致其发展到不可逆阶段。 细胞外基质
肾小球毛细血管合成(瘢痕形成)与内皮损伤
是关键特征。 肾小球瘢痕形成表明
促进纤维形成的因子的表达和合成。 另
另一方面,肾小球毛细血管内皮的损伤可能表明,
内皮衍生因子的合成可能因此受到干扰
引起肾血流动力学损害。 我们已经证明血管紧张素II
(AII)合成抑制剂保护大鼠肾功能和结构
放射性肾病模型。 这意味着生物事件触发了
作为辐射发病机制的潜在机制
肾病 两个可能的事件是,ECM促进因子的合成
转化生长因子(TGF)-β 1与内皮源性
血管扩张剂一氧化氮 拟议的研究将使用大鼠模型,
放射性肾病,以检验以下假设:
1)在放射性肾病中,
细胞外基质(ECM)蛋白和增强表达TGF-β 1,
促进这些ECM蛋白的合成。 AII抑制减弱TGF-β 1
ECM蛋白的表达和合成。 2)在辐射诱导
肾病中存在肾小球毛细血管内皮的损伤。 这
导致内皮衍生的血管扩张剂的产生受损,
一氧化氮(NO),从而改变肾小球中的压力和流量
微脉管系统 AII合成抑制恢复或促进NO
生成,从而改善肾缺血。 预计该
观察将增强我们对
辐射引起的伤害,并提供手段,以避免其发展,
不可逆转的阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elias Lianos其他文献
Elias Lianos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elias Lianos', 18)}}的其他基金
Novel Complement-targeted treatment strategies in Renal Disease
肾病补体靶向治疗新策略
- 批准号:
10057225 - 财政年份:2019
- 资助金额:
$ 19.36万 - 项目类别:
Novel Complement-targeted treatment strategies in Renal Disease
肾病补体靶向治疗新策略
- 批准号:
10516066 - 财政年份:2019
- 资助金额:
$ 19.36万 - 项目类别:
Novel Complement-targeted treatment strategies in Renal Disease
肾病补体靶向治疗新策略
- 批准号:
10292974 - 财政年份:2019
- 资助金额:
$ 19.36万 - 项目类别:
RENAL IMMUNE INJURY--NO/EICOSANOID INTERACTIONS
肾免疫损伤——无/二十烷酸相互作用
- 批准号:
6086125 - 财政年份:1997
- 资助金额:
$ 19.36万 - 项目类别:
RENAL IMMUNE INJURY--NO/EICOSANOID INTERACTIONS
肾免疫损伤——无/二十烷酸相互作用
- 批准号:
2410085 - 财政年份:1997
- 资助金额:
$ 19.36万 - 项目类别:
RENAL IMMUNE INJURY--NO/EICOSANOID INTERACTIONS
肾免疫损伤——无/二十烷酸相互作用
- 批准号:
2905866 - 财政年份:1997
- 资助金额:
$ 19.36万 - 项目类别:
RENAL IMMUNE INJURY--NO/EICOSANOID INTERACTIONS
肾免疫损伤——无/二十烷酸相互作用
- 批准号:
6177525 - 财政年份:1997
- 资助金额:
$ 19.36万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 19.36万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 19.36万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 19.36万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 19.36万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 19.36万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 19.36万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 19.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




